DGAP-Adhoc: STADA: Carl Ferdinand Oetker appointed new Member of the Supervisory Board


STADA Arzneimittel AG / Change of Personnel

17.11.2009 

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Bad Vilbel, November 17, 2009 - Effective November 13, 2009, the District
Court of Frankfurt am Main has, based on a joint proposal of the
Supervisory Board and Executive Board, appointed Carl Ferdinand Oetker (37)
as new Member of the Supervisory Board of STADA Arzneimittel AG.

Oetker is General Agent at Bankhaus Lampe KG. In addition, Oetker performs
a number of mandates in various companies. He heads the Advisory Boards at
EWABO Chemikalien GmbH & Co. KG as well as wink Stanzwerkzeuge GmbH & Co.
KG, in which he also holds substantial investments. A list of Oetkers
mandates has been published on STADA's website. His professional career
also includes stops at ING BHF-BANK Aktiengesellschaft, AXA Investment
Managers Deutschland GmbH, Schroder Fonds Service GmbH as well as The
Boston Consulting Group.

On August 24, 2009, Supervisory Board Member Uwe E. Flach resigned his
position as Member of the Supervisory Board as of September 24, 2009, after
the one-month period stipulated by the Company's articles of incorporation
(see the Company's ad hoc release of August 24, 2009). With today's
appointment of financial expert Oetker, the Supervisory Board of the STADA
Group is once again complete with six shareholder representatives and three
employee representatives.

The period in office for the replacement member von Oetker is limited to
the time until the end of the Annual General Meeting on June 8, 2010 at
which, in accordance with Section 12 (3) of the Company's articles of
incorporation, an election is to take place.

Further information:
STADA Arzneimittel AG / Corporate Communications / Stadastraße 2-18 /
D61118 Bad Vilbel /
Phone: +49 (0) 6101 603-113 / Fax: +49 (0) 6101 603-506 / E-Mail:
communications@stada.de
Or visit our website at www.stada.com.


17.11.2009  Financial News distributed by DGAP. Medienarchiv at |[![CDATA[|[a href="http://www.dgap-medientreff.de"|]www.dgap-medientreff.de|[/a|]]]|] and |[![CDATA[|[a href="http://www.dgap.de"|]www.dgap.de|[/a|]]]|]

---------------------------------------------------------------------------
 
Language:     English
Company:      STADA Arzneimittel AG
              Stadastraße 2-18
              61118 Bad Vilbel
              Deutschland
Phone:        +49 (0)6101 603- 113
Fax:          +49 (0)6101 603- 506
E-mail:       communications@stada.de
Internet:     www.stada.de
ISIN:         DE0007251803, DE0007251845, 
WKN:          725180, 725184, 
Indices:      MDAX
Listed:       Regulierter Markt in Frankfurt (Prime Standard), Düsseldorf;
              Freiverkehr in Berlin, Hannover, München, Hamburg, Stuttgart
 
End of News                                     DGAP News-Service
 
---------------------------------------------------------------------------